Skip to content

Abnormal Glycohemoglobin Control

by Analytical Control Systems Inc

510(k) K902457

Abnormal Glycohemoglobin Control is a medical device (FDA Class II; FDA product code LCP, Assay, Glycosylated Hemoglobin) made by Analytical Control Systems Inc, cleared under FDA 510(k) K902457 on 24 Jul 1990, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK902457 Date24 Jul 1990ClearedStatusActive

Official records

From the FDA record

Received by the FDA
4 Jun 1990
FDA decision
24 Jul 1990 (Substantially Equivalent)
FDA review time
50 days from receipt to decision

From the FDA 510(k) record K902457 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
LCP
FDA applicant
Analytical Control Systems, Inc.
Device class
Class II
Regulation
21 CFR Part 864.7470
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code LCP (Assay, Glycosylated Hemoglobin).

Other devices from Analytical Control Systems

See all devices from Analytical Control Systems →